Plan B One-Step Makes OTC Debut But Cost Concerns Linger
This article was originally published in The Tan Sheet
Executive Summary
Teva’s Plan B One-Step launches on retail shelves nationwide and sells for around $50 a dose. Slightly less expensive generic equivalents remain behind the pharmacy counter, though some say FDA may be open to sponsors applying for OTC status with a 17-years-and-older age restriction.